Stiller CA, Parkin DM (1992) International variations in the incidence of neuroblastoma. International Journal of Cancer 52:538-543

Schwab M, Westermann F, Hero B, Berthold F (2003) Neuroblastoma: biology and molecular and chromosomal pathology. The Lancet Oncology 4:472-480

Cheung N, Dyer M (2013) Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nature reviews Cancer 13:397-411

Matthay K, Maris J, Schleiermacher G, Nakagawara A, Mackall C, Diller L, Weiss W (2016) Neuroblastoma. Nature reviews Disease primers 2:16078

Maris J, Hogarty M, Bagatell R, Cohn S (2007) Neuroblastoma. Lancet (London, England) 369:2106-2120

Suita S, Tajiri T, Sera Y, Takamatsu H, Mizote H, Ohgami H, Kurosaki N, Hara T, Okamura J, Miyazaki S, Sugimoto T, Kawakami K, Tsuneyoshi M, Tasaka H, Yano H, Akiyama H, Ikeda K (2000) The characteristics of mediastinal neuroblastoma. European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery [et al] = Zeitschrift fur Kinderchirurgie 10:353-359

Choi JH, Ro JY (2022) Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: pathology review and diagnostic approach. Seminars in Diagnostic Pathology 39:120-130

Swift CC, Eklund MJ, Kraveka JM, Alazraki AL (2018) Updates in diagnosis, management, and treatment of neuroblastoma. RadioGraphics 38:566-580

Qiu B, Matthay K (2022) Advancing therapy for neuroblastoma. Nature reviews Clinical oncology 19:515-533

Hao J, Sang J, Xu X, Bao A (2023) Diagnostic value of CT and MRI combined with serum LDH, NSE, CEA, and MYCN in pediatric neuroblastoma. World journal of surgical oncology 21:251

Georgantzi K, Sköldenberg EG, Stridsberg M, Kogner P, Jakobson Å, Janson ET, Christofferson RHB (2018) Chromogranin A and neuron-specific enolase in neuroblastoma: correlation to stage and prognostic factors. Pediatric Hematology and Oncology 35:156-165

Wang X, Wang L, Su Y, Yue Z, Xing T, Zhao W, Zhao Q, Duan C, Huang C, Zhang D, Jin M, Cheng X, Chen S, Liu Y, Ma X (2018) Plasma cell-free DNA quantification is highly correlated to tumor burden in children with neuroblastoma. Cancer Medicine 7:3022-3030

Yang R, Zheng S, Dong R (2023) Circulating tumor cells in neuroblastoma: current status and future perspectives. Cancer medicine 12:7-19

Pantel K, Alix-Panabières C (2019) Liquid biopsy and minimal residual disease — latest advances and implications for cure. Nature Reviews Clinical Oncology 16:409-424

Labib M, Kelley S (2021) Circulating tumor cell profiling for precision oncology. Molecular oncology 15:1622-1646

Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson AD (2009) The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 27:298-303

Kushner B, Cheung N, LaQuaglia M, Ambros P, Ambros I, Bonilla M, Ladanyi M, Gerald W (1996) International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 14:2174-2180

Wang LL, Teshiba R, Ikegaki N, Tang XX, Naranjo A, London WB, Hogarty MD, Gastier-Foster JM, Look AT, Park JR (2015) Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group study. British Journal of Cancer 113:57-63

Panachan J, Rojsirikulchai N, Pongsakul N, Khowawisetsut L, Pongphitcha P, Siriboonpiputtana T, Chareonsirisuthigul T, Phornsarayuth P, Klinkulab N, Jinawath N, Chiangjong W, Anurathapan U, Pattanapanyasat K, Hongeng S, Chutipongtanate S (2022) Extracellular vesicle-based method for detecting MYCN amplification status of pediatric neuroblastoma. Cancers (Basel) 14

Campbell K, Gastier-Foster JM, Mann M, Naranjo AH, Dubois SG (2017) Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group. Cancer 123

R AT (1869) A case of cancer in which cells similar to those in the tumours were seen in the blood after death. The Medical Journal of Australia:146-147

Rack B, Schindlbeck C, Jückstock J, Andergassen U, Hepp P, Zwingers T, Friedl T, Lorenz R, Tesch H, Fasching P, Fehm T, Schneeweiss A, Lichtenegger W, Beckmann M, Friese K, Pantel K, Janni W (2014) Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. Journal of the National Cancer Institute 106

Aceto N, Bardia A, Miyamoto David T, Donaldson Maria C, Wittner Ben S, Spencer Joel A, Yu M, Pely A, Engstrom A, Zhu H, Brannigan Brian W, Kapur R, Stott Shannon L, Shioda T, Ramaswamy S, Ting David T, Lin Charles P, Toner M, Haber Daniel A, Maheswaran S (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158:1110-1122

Vilalta M, Rafat M, Giaccia AJ, Graves EE (2014) Recruitment of circulating breast cancer cells is stimulated by radiotherapy. Cell reports 8:402-409

Pierga J, Bidard F, Mathiot C, Brain E, Delaloge S, Giachetti S, de Cremoux P, Salmon R, Vincent-Salomon A, Marty M (2008) Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clinical cancer research: an official journal of the American Association for Cancer Research 14:7004-7010

Papadaki MA, Koutsopoulos AV, Tsoulfas PG, Lagoudaki E, Agelaki S (2020) Clinical relevance of immune checkpoints on circulating tumor cells in breast cancer. Cancers 12:376

Andre F, Ismaila N, Allison K, Barlow W, Collyar D, Damodaran S, Henry N, Jhaveri K, Kalinsky K, Kuderer N, Litvak A, Mayer E, Pusztai L, Raab R, Wolff A, Stearns V (2022) Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40:1816-1837

Tamminga M, de Wit S, Hiltermann T, Timens W, Schuuring E, Terstappen L, Groen H (2019) Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors. Journal for immunotherapy of cancer 7:173

Zhu H, Liu Y, Feng Y, Zhang L, Zhang T, Dong G, Xing P, Wang H, Shi Y, Hu X (2021) Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis. Thoracic cancer 12:2749-2757

Moon S, Kim J, Kim S, Kim S, Kwon H, Bae J, Lee S, Lee H, Choi M, Jeon B, Jeong B, Lee K, Kim H, Kim J, Um S (2020) Clinical utility of combined circulating tumor cell and circulating tumor DNA assays for diagnosis of primary lung cancer. Anticancer research 40:3435-3444

Kanayama M, Kuwata T, Mori M, Nemoto Y, Nishizawa N, Oyama R, Matsumiya H, Taira A, Shinohara S, Takenaka M, Yoneda K, Kuroda K, Ohnaga T, Tanaka F (2022) Prognostic impact of circulating tumor cells detected with the microfluidic “universal CTC-chip” for primary lung cancer. Cancer science 113:1028-1037

Biller L, Schrag D (2021) Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA 325:669-685

Li M, Wu S, Zhuang C, Shi C, Gu L, Wang P, Guo F, Wang Y, Liu Z (2023) Metabolomic analysis of circulating tumor cells derived liver metastasis of colorectal cancer. Heliyon 9

Ring A, Nguyen-Sträuli BD, Wicki A, Aceto N (2022) Biology, vulnerabilities and clinical applications of circulating tumour cells. Nature Reviews Cancer

Ahn J, Teng P, Chen P, Posadas E, Tseng H, Lu S, Yang J (2021) Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology (Baltimore, Md) 73:422-436

Palmela Leitão T, Miranda M, Polido J, Morais J, Corredeira P, Alves P, Oliveira T, Pereira E Silva R, Fernandes R, Ferreira J, Palma Reis J, Lopes T, Costa L (2021) Circulating tumor cell detection methods in renal cell carcinoma: a systematic review. Critical reviews in oncology/hematology 161:103331

Xiangqi, Liu, Zhenzhen, Zhang, Binbin, Yijie, Zheng, Chao, Baihui, Shan (2018) Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization. Ebiomedicine

Liu Z, Huang Y, Liang W, Bai J, Feng H, Fang Z, Tian G, Zhu Y, Zhang H, Wang Y, Liu A, Chen Y (2021) Cascaded filter deterministic lateral displacement microchips for isolation and molecular analysis of circulating tumor cells and fusion cells. Lab on a chip 21:2881-2891

Zeineldin M, Patel A, Dyer M (2022) Neuroblastoma: when differentiation goes awry. Neuron 110:2916-2928

Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F, Foster J, Zhou J, Zhang R (2021) Molecular targeting therapies for neuroblastoma: progress and challenges. Medicinal research reviews 41:961-1021

Yue Z, Gao C, Xing T, Zhao W, Duan C, Wang X, Jin M, Su Y (2023) Combined analysis of PHOX2B at two time points and its value for further risk stratification in high-risk neuroblastoma. Pediatric blood & cancer 70:e30261

Cangemi G, Reggiardo G, Barco S, Barbagallo L, Conte M, D'Angelo P, Bianchi M, Favre C, Galleni B, Melioli G, Haupt R, Garaventa A, Corrias MV (2012) Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma. OncoTargets and therapy 5:417-423

Zeltzer P, Parma A, Dalton A, Siegel S, Marangos P, Sather H, Hammond D, Seeger R (1983) Raised neuron-specific enolase in serum of children with metastatic neuroblastoma: a report from the Children’s Cancer Study Group. The Lancet 322:361-363

Tsuchida Y, Honna T, Iwanaka T, Saeki M, Taguchi N, Kaneko T, Koide R, Tsunematsu Y, Shimizu K-i, Makino S-i, Hashizume K, Nakajo T (1987) Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors. Journal of Pediatric Surgery 22:419-424

Merugu S, Chen L, Gavens E, Gabra H, Brougham M, Makin G, Ng A, Murphy D, Gabriel A, Robinson M, Wright J, Burchill S, Humphreys A, Bown N, Jamieson D, Tweddle D (2020) Detection of circulating and disseminated neuroblastoma cells using the ImageStream flow cytometer for use as predictive and pharmacodynamic biomarkers. Clinical cancer research: an official journal of the American Association for Cancer Research 26:122-134

Batth I, Dao L, Satelli A, Mitra A, Yi S, Noh H, Li H, Brownlee Z, Zhou S, Bond J, Wang J, Gill J, Sholler G, Li S (2020) Cell surface vimentin-positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of postremission neuroblastoma patients. International journal of cancer 147:3550-3559

Uemura S, Ishida T, Thwin K, Yamamoto N, Tamura A, Kishimoto K, Hasegawa D, Kosaka Y, Nino N, Lin K, Takafuji S, Mori T, Iijima K, Nishimura N (2019) Dynamics of minimal residual disease in neuroblastoma patients. Frontiers in oncology 9:455

Yang D-d, Liu C, Gao J, Hu Q-j, Liang Y, Liu J (2023) Association of image-defined risk factors with clinical features, tumor biology, and outcomes in neuroblastoma: a single-center retrospective study. European Journal of Pediatrics 182:2189-2196

Kojima M, Harada T, Fukazawa T, Kurihara S, Touge R, Saeki I, Takahashi S, Hiyama E (2023) Single-cell next-generation sequencing of circulating tumor cells in patients with neuroblastoma. Cancer science 114:1616-1624

Jansky S, Sharma A, Körber V, Quintero A, Toprak U, Wecht E, Gartlgruber M, Greco A, Chomsky E, Grünewald T, Henrich K, Tanay A, Herrmann C, Höfer T, Westermann F (2021) Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma. Nature genetics 53:683-693

Fetahu I, Esser-Skala W, Dnyansagar R, Sindelar S, Rifatbegovic F, Bileck A, Skos L, Bozsaky E, Lazic D, Shaw L, Tötzl M, Tarlungeanu D, Bernkopf M, Rados M, Weninger W, Tomazou E, Bock C, Gerner C, Ladenstein R, Farlik M, Fortelny N, Taschner-Mandl S (2023) Single-cell transcriptomics and epigenomics unravel the role of monocytes in neuroblastoma bone marrow metastasis. Nature communications 14:3620